Improving Impaired Cognitive Function with Novel Neurogenic Agent, NNI-362: A Dose Response Study

Project Details

StatusFinished
Effective start/end date1/06/12 → 30/06/13

Funding

  • Classified: $20,000.00

Keywords

  • Aging & Alzheimers